BioInvent International AB (publ) (FRA:BIX0)

Germany · Delayed Price · Currency is EUR

2.490

+0.050 (2.05%)

Last updated: Feb 23, 2026, 8:04 AM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Develops Antibody-Based Drugs	44.69M	71.46M	326.13M	19.38M	147.37M
Develops Antibody-Based Drugs Growth	-37.47%	-78.09%	1582.45%	-86.85%	57.21%
Total	44.69M	71.46M	326.13M	19.38M	147.37M
Total Growth	-37.47%	-78.09%	1582.45%	-86.85%	57.21%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Sweden	3.89M	18.26M	25.63M	13.52M	2.75M
Sweden Growth	-78.72%	-28.75%	89.67%	391.99%	-88.55%
Europe	2.93M	2.95M	27.10M	4.21M	34.27M
Europe Growth	-0.85%	-89.11%	543.29%	-87.71%	3041.06%
USA	36.82M	47.39M	273.39M	1.66M	89.69M
USA Growth	-22.30%	-82.66%	16409.06%	-98.15%	48.12%
Other Countries	1.05M	2.85M	-	-	-
Other Countries Growth	-63.17%	-	-	-	-
Japan	-	-	-	-	20.67M
Japan Growth	-	-	-	-	154.90%
Total	44.69M	71.46M	326.13M	19.38M	147.37M
Total Growth	-37.47%	-78.09%	1582.45%	-86.85%	57.21%

Source: S&P Global Market Intelligence.